The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest surviv...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Frontiers Media
2024
|
| _version_ | 1826314506253369344 |
|---|---|
| author | Chow, J Leong, KMW Shun-Shin, M Jones, S Guttmann, OP Mohiddin, SA Lambiase, P Elliott, PM Ormerod, JOM Koa-Wing, M Lefroy, D Lim, PB Linton, NWF Ng, FS Qureshi, NA Whinnett, ZI Peters, NS Francis, DP Varnava, AM Kanagaratnam, P |
| author_facet | Chow, J Leong, KMW Shun-Shin, M Jones, S Guttmann, OP Mohiddin, SA Lambiase, P Elliott, PM Ormerod, JOM Koa-Wing, M Lefroy, D Lim, PB Linton, NWF Ng, FS Qureshi, NA Whinnett, ZI Peters, NS Francis, DP Varnava, AM Kanagaratnam, P |
| author_sort | Chow, J |
| collection | OXFORD |
| description | Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest survivors. Methods: HCM patients surviving ventricular fibrillation or hemodynamically unstable ventricular tachycardia (n = 17) were compared to HCM patients without a personal history of potentially lethal arrhythmia (n = 20) and a pooled control group with structurally normal hearts. Subjects underwent exercise testing by non-invasive electrocardiographic imaging to estimate epicardial electrophysiology. Results: Visual inspection of reconstructed epicardial HCM maps revealed isolated patches of late activation time (AT), prolonged activation-recovery intervals (ARIs), as well as reversal of apico-basal trends in T-wave inversion and ARI compared to controls (p < 0.005 for all). AT and ARI were compared between groups. The pooled HCM group had longer mean AT (60.1 ms vs. 52.2 ms, p < 0.001), activation dispersion (55.2 ms vs. 48.6 ms, p = 0.026), and mean ARI (227 ms vs. 217 ms, p = 0.016) than structurally normal heart controls. HCM ventricular arrhythmia survivors could be differentiated from HCM patients without a personal history of life-threatening arrhythmia by longer mean AT (63.2 ms vs. 57.4 ms, p = 0.007), steeper activation gradients (0.45 ms/mm vs. 0.36 ms/mm, p = 0.011), and longer mean ARI (234.0 ms vs. 221.4 ms, p = 0.026). A logistic regression model including whole heart mean activation time and activation recovery interval could identify ventricular arrhythmia survivors from the HCM cohort, producing a C statistic of 0.76 (95% confidence interval 0.72–0.81), with an optimal sensitivity of 78.6% and a specificity of 79.8%. Discussion: The HCM epicardial electrotype is characterized by delayed, dispersed conduction and prolonged, dispersed activation-recovery intervals. Combination of electrophysiologic measures with logistic regression can improve differentiation over single variables. Future studies could test such models prospectively for risk stratification of sudden death due to HCM. |
| first_indexed | 2024-09-25T04:35:07Z |
| format | Journal article |
| id | oxford-uuid:77f3ccd3-e30d-473a-a7db-63a355f8f49a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:35:07Z |
| publishDate | 2024 |
| publisher | Frontiers Media |
| record_format | dspace |
| spelling | oxford-uuid:77f3ccd3-e30d-473a-a7db-63a355f8f49a2024-09-13T20:03:58ZThe arrhythmic substrate of hypertrophic cardiomyopathy using ECG imagingJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:77f3ccd3-e30d-473a-a7db-63a355f8f49aEnglishJisc Publications RouterFrontiers Media2024Chow, JLeong, KMWShun-Shin, MJones, SGuttmann, OPMohiddin, SALambiase, PElliott, PMOrmerod, JOMKoa-Wing, MLefroy, DLim, PBLinton, NWFNg, FSQureshi, NAWhinnett, ZIPeters, NSFrancis, DPVarnava, AMKanagaratnam, PIntroduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest survivors. Methods: HCM patients surviving ventricular fibrillation or hemodynamically unstable ventricular tachycardia (n = 17) were compared to HCM patients without a personal history of potentially lethal arrhythmia (n = 20) and a pooled control group with structurally normal hearts. Subjects underwent exercise testing by non-invasive electrocardiographic imaging to estimate epicardial electrophysiology. Results: Visual inspection of reconstructed epicardial HCM maps revealed isolated patches of late activation time (AT), prolonged activation-recovery intervals (ARIs), as well as reversal of apico-basal trends in T-wave inversion and ARI compared to controls (p < 0.005 for all). AT and ARI were compared between groups. The pooled HCM group had longer mean AT (60.1 ms vs. 52.2 ms, p < 0.001), activation dispersion (55.2 ms vs. 48.6 ms, p = 0.026), and mean ARI (227 ms vs. 217 ms, p = 0.016) than structurally normal heart controls. HCM ventricular arrhythmia survivors could be differentiated from HCM patients without a personal history of life-threatening arrhythmia by longer mean AT (63.2 ms vs. 57.4 ms, p = 0.007), steeper activation gradients (0.45 ms/mm vs. 0.36 ms/mm, p = 0.011), and longer mean ARI (234.0 ms vs. 221.4 ms, p = 0.026). A logistic regression model including whole heart mean activation time and activation recovery interval could identify ventricular arrhythmia survivors from the HCM cohort, producing a C statistic of 0.76 (95% confidence interval 0.72–0.81), with an optimal sensitivity of 78.6% and a specificity of 79.8%. Discussion: The HCM epicardial electrotype is characterized by delayed, dispersed conduction and prolonged, dispersed activation-recovery intervals. Combination of electrophysiologic measures with logistic regression can improve differentiation over single variables. Future studies could test such models prospectively for risk stratification of sudden death due to HCM. |
| spellingShingle | Chow, J Leong, KMW Shun-Shin, M Jones, S Guttmann, OP Mohiddin, SA Lambiase, P Elliott, PM Ormerod, JOM Koa-Wing, M Lefroy, D Lim, PB Linton, NWF Ng, FS Qureshi, NA Whinnett, ZI Peters, NS Francis, DP Varnava, AM Kanagaratnam, P The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging |
| title | The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging |
| title_full | The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging |
| title_fullStr | The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging |
| title_full_unstemmed | The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging |
| title_short | The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging |
| title_sort | arrhythmic substrate of hypertrophic cardiomyopathy using ecg imaging |
| work_keys_str_mv | AT chowj thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT leongkmw thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT shunshinm thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT joness thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT guttmannop thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT mohiddinsa thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT lambiasep thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT elliottpm thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT ormerodjom thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT koawingm thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT lefroyd thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT limpb thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT lintonnwf thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT ngfs thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT qureshina thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT whinnettzi thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT petersns thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT francisdp thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT varnavaam thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT kanagaratnamp thearrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT chowj arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT leongkmw arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT shunshinm arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT joness arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT guttmannop arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT mohiddinsa arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT lambiasep arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT elliottpm arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT ormerodjom arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT koawingm arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT lefroyd arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT limpb arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT lintonnwf arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT ngfs arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT qureshina arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT whinnettzi arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT petersns arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT francisdp arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT varnavaam arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging AT kanagaratnamp arrhythmicsubstrateofhypertrophiccardiomyopathyusingecgimaging |